Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.
| Revenue (TTM) | 18,110 |
| Gross Profit (TTM) | 14,340 |
| EBITDA | $-8.33M |
| Operating Margin | -1418414.00% |
| Return on Equity | -148.20% |
| Return on Assets | -33.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.93 |
| Price-to-Book | 1.95 |
| Price-to-Sales (TTM) | 622.15 |
| EV/Revenue | 1217.78 |
| EV/EBITDA | -1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -99.80% |
| Shares Outstanding | $7.36M |
| Float | $2.36M |
| % Insiders | 64.13% |
| % Institutions | 1.56% |
Volatility is currently contracting